Media
News item on site Radboud university medical center:
Funding for research into drug against systemic sclerosis
Radboudumc Holding one of several investors in startup Philikos
Publication Annals Rheumatic Diseases on Systemic Sclerosis:
CD7 activation regulates cytotoxicity-driven pathology in systemic sclerosis, yielding a target for selective cell depletion
YouTube film ARD: